{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-012356","form_type":"8-K","ticker":"IRMD","cik":"0001325618","company_name":"IRADIMED CORP","filed_at":"2026-02-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.793927+00:00","generated_at":"2026-05-16T03:32:02.148415+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Iradimed reports record Q4 revenue $22.7M, EPS $0.50; raises dividend to $0.20","bullets":["Q4 2025 revenue $22.7M (+17% YoY); GAAP diluted EPS $0.50 (+25%), non-GAAP $0.54 (+23%).","Full year 2025 revenue $83.8M (+14% YoY); GAAP diluted EPS $1.75 (+17%), non-GAAP $1.93 (+16%).","Quarterly dividend raised 18% to $0.20/share from $0.17, payable March 6, 2026 to holders of record Feb 23.","FY2026 guidance: revenue $91-96M, GAAP EPS $1.90-2.05, non-GAAP EPS $2.06-2.21.","Initial 3870 next-gen MRI pump shipped in Q4; full rollout begins Q1 2026 with meaningful H2 revenue contribution."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-012356","json":"https://secwatch.observer/filing/0001104659-26-012356.json","markdown":"https://secwatch.observer/filing/0001104659-26-012356.md","text":"https://secwatch.observer/filing/0001104659-26-012356.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1325618/000110465926012356/0001104659-26-012356-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1325618/000110465926012356/irmd-20260210x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T03:32:02.148415+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}